pyrimidine has been researched along with Diseases, Metabolic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Freeze, HH; Gahl, WA; He, M; Ichikawa, M; Markello, T; Ng, BG; Tifft, CJ; Wolfe, LA | 1 |
Brown, CJ; Heifetz, A; Moeller, C; Mueller, SG; Nosse, B; Pedret-Dunn, A; Prestle, J; Prevost, N; Scheuerer, S; Schindler, M; Tye, H; Whittaker, M | 1 |
2 other study(ies) available for pyrimidine and Diseases, Metabolic
Article | Year |
---|---|
Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors.
Topics: Animals; Aspartate Carbamoyltransferase; Base Sequence; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Child, Preschool; CHO Cells; Cricetinae; Cricetulus; Dihydroorotase; DNA Mutational Analysis; Genetic Association Studies; Glycosylation; Heterozygote; Humans; Male; Metabolic Diseases; Mutation, Missense; Protein Processing, Post-Translational; Pyrimidines; Sequence Deletion | 2015 |
Novel 6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohepta[f]indene analogues as potent and selective 5-HT(2C) agonists for the treatment of metabolic disorders.
Topics: Animals; Aza Compounds; Azepines; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Heterocyclic Compounds, 3-Ring; Humans; Indenes; Male; Metabolic Diseases; Pyrimidines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Structure-Activity Relationship | 2011 |